Bevacizumab vs Ranibizumab for Age-Related Macular Degeneration: Early Results of a Prospective Double-Masked, Randomized Clinical Trial REPLY

被引：0
|
作者：
Subramanian, Manju
机构：
来源：
AMERICAN JOURNAL OF OPHTHALMOLOGY | 2010年 / 150卷 / 02期
关键词：
D O I：
10.1016/j.ajo.2010.04.004
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：287 / 287
页数：1
相关论文
共 50 条
  • [41] Efficacy and Safety of a Proposed Ranibizumab Biosimilar Product vs a Reference Ranibizumab Product for Patients With Neovascular Age-Related Macular Degeneration A Randomized Clinical Trial
    Woo, Se Joon
    Veith, Miroslav
    Hamouz, Jan
    Ernest, Jan
    Zalewski, Dominik
    Studnicka, Jan
    Vajas, Attila
    Papp, Andras
    Gabor, Vogt
    Luu, James
    Matuskova, Veronika
    Yoon, Young Hee
    Pregun, Tamas
    Kim, Taehyung
    Shin, Donghoon
    Bressler, Neil M.
    JAMA OPHTHALMOLOGY, 2021, 139 (01) : 68 - 76
  • [42] Macular Atrophy in Neovascular Age-Related Macular Degeneration A Randomized Clinical Trial Comparing Ranibizumab and Aflibercept (RIVAL Study)
    Gillies, Mark C.
    Hunyor, Alex P.
    Arnold, Jennifer J.
    Guymer, Robyn H.
    Wolf, Sebastian
    Pecheur, Francois L.
    Munk, Marion R.
    McAllister, Ian L.
    OPHTHALMOLOGY, 2020, 127 (02) : 198 - 210
  • [43] Combination of ranibizumab and indomethacin for neovascular age-related macular degeneration: randomized controlled trial
    Russo, Andrea
    Scaroni, Nicolo
    Gambicorti, Elena
    Turano, Raffaele
    Morescalchi, Francesco
    Costagliola, Ciro
    Semeraro, Francesco
    CLINICAL OPHTHALMOLOGY, 2018, 12 : 587 - 591
  • [44] Age-related macular degeneration: Analysis of the results of ranibizumab therapy
    Casaroli-Marano, Ricardo
    Adan, Alfredo
    Gomez-Ulla, Francisco
    Maria Diaz, Josep
    MEDICINA CLINICA, 2011, 136 (03): : 128 - 129
  • [45] Bevacizumab vs ranibizumab treatment for age-related macular degeneration - A head-to-head comparison is needed
    Jampol, Lee M.
    ARCHIVES OF OPHTHALMOLOGY, 2007, 125 (04) : 557 - 558
  • [46] Tissue plasminogen activator-assisted surgical excision of subfoveal choroidal neovascularization in age-related macular degeneration - A randomized, double-masked trial - Discussion
    Aaberg, TM
    OPHTHALMOLOGY, 1997, 104 (11) : 1852 - 1852
  • [47] Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration
    Moja, Lorenzo
    Lucenteforte, Ersilia
    Kwag, Koren H.
    Bertele, Vittorio
    Campomori, Annalisa
    Chakravarthy, Usha
    D'Amico, Roberto
    Dickersin, Kay
    Kodjikian, Laurent
    Lindsley, Kristina
    Loke, Yoon
    Maguire, Maureen
    Martin, Daniel F.
    Mugelli, Alessandro
    Muehlbauer, Bernd
    Puentmann, Isabel
    Reeves, Barnaby
    Rogers, Chris
    Schmucker, Christine
    Subramanian, Manju L.
    Virgili, Gianni
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (09):
  • [48] Bevacizumab and ranibizumab in exudative age-related macular degeneration: Is the effectiveness conditioned by accessibility?
    Luna Pinto, Jose
    Real, Juan
    Urrets-Zavalia, Julio
    Juarez, Claudio
    Palma, Santiago
    Granero, Gladys
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [49] Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration The CATT Research Group
    Martin, Daniel F.
    Maguire, Maureen G.
    Ying, Gui-shuang
    Grunwald, Juan E.
    Fine, Stuart L.
    Jaffe, Glenn J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (20): : 1897 - 1908
  • [50] MERLIN: Phase 3a, Multicenter, Randomized, Double-Masked Trial of Brolucizumab in Participants with Neovascular Age-Related Macular Degeneration and Persistent Retinal Fluid
    Khanani, Arshad M.
    Brown, David M.
    Jaffe, Glenn J.
    Wykoff, Charles C.
    Adiguzel, Eser
    Wong, Randall
    Meng, Xiangyi
    Heier, Jeffrey S.
    OPHTHALMOLOGY, 2022, 129 (09) : 974 - 985
12345